跳至主要内容
临床试验/NCT07480785
NCT07480785招募中不适用

Transcutaneous Electrical Acupoint Stimulation Combined With Triple Antiemetic Drugs for Postoperative Nausea and Vomiting in High-Risk Patients: A Multicenter Randomized Controlled Trial

Zhejiang University1 个研究点 分布在 1 个国家目标入组 780 人开始时间: 2026年1月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
780
试验地点
1
主要终点
Number of Participants Experiencing Nausea,Retching and Vomiting within 24 hours after operation.

研究概览

简要总结

The goal of this clinical trial is to evaluate the effects of transcutaneous electrical acupoint stimulation (TEAS) combined with triple antiemetics for postoperative nausea and vomiting (PONV) in high-risk patients.

The primary question it seeks to answer is:

Does TEAS combined with triple antiemetics further reduce the incidence of PONV in high-risk subjects? Researchers will compare active TEAS with sham stimulation to determine whether the addition of TEAS to dexamethasone, palonosetron, and droperidol lowers the PONV rate beyond that achieved by the triple-drug prophylaxis alone.

详细描述

780 female patients, aged between 18 to 65 y, who are scheduled for elective laparoscopic surgery requiring general anesthesia, will be randomly allocated to acustimulation group (Group TEAS), or the control group.

In Group TEAS, a surface electrode will be applied to the P6 and L14 acupoint 30 min before induction. An operator will set electric stimulating current at 1mA with frequency at 2 Hz, and gradually increased the current intensity to a little below discomfort threshold. The stimulation will be maintained until the patient is discharged from the operation. In the control group the same protocol was applied for percutaneous acupoint electrical stimulation, initiated before anesthesia induction with the minimum perceptible current (MPC) and terminated after 1 minute.

A standardized anesthetic protocol will be followed. In all groups, dexamethasone 5mg and palonosetron 0.25mg i.v. will be given after induction, and droperidol 1.25 mg i.v. will be given during the abdominal closure. After surgery, metoclopramide 10mg i.v. will be administered as a rescue therapy to any patient who experiences an episode of moderate or severe nausea, an episode of vomiting, and requests rescue medication.

The patients shall be unaware of the group assignments. An anesthesiologist, who are trained for the study and blinded to the randomization, will collect the data.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

盲法说明

Both acupoint stimulation and placebo treatment will be administered by the same investigator, who will take no part in anesthesia management or data collection. To maintain blinding, an opaque drape will be placed over the TEAS unit in both groups. All participants will be informed that they may or may not feel a tingling sensation at the wrists while the device is operating. Follow-up and data collection will be performed by a separate investigator who is uninvolved in routine anesthesia care and blinded to group allocation.

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women scheduled for laparoscopic surgery ;
  • Aged 18-65 years;
  • ASA Class I-III;
  • Apfel score ≥ 3 (female sex, non-smoker, history of PONV and/or motion sickness).

排除标准

  • Patients with a history of allergy to the investigational drug or contraindications;
  • Long-QT syndrome ;
  • Pregnancy, lactation, or menstruation ;
  • Current smoker;
  • Nausea/vomiting or use of antiemetics, opioids, or systemic corticosteroids within 24 h before surgery;
  • Requirement for post-operative sedation and mechanical ventilation ;
  • Severe renal or hepatic impairment ;
  • Psychiatric or neurological disorder ;
  • Vertebrobasilar insufficiency;
  • Vestibular disease;
  • Language or communication barrier ;
  • Skin lesion or infection at the acupoint stimulation site ;
  • Upper-limb nerve injury ;
  • Implanted cardiac pacemaker or defibrillator ;
  • Participation in another clinical trial within the past 4 weeks.

研究组 & 干预措施

The TEAS group

Experimental

The TEAS group,Nei-guan (PC6) and He-gu (LI4) were stimulated by a transcutaneous acupoint electrical stimulation instrument approximately 30 minutes before anesthesia induction until the patient is discharged from the operating room.

干预措施: transcutaneous electrical acupoint stimulation (Device)

The TEAS group

Experimental

The TEAS group,Nei-guan (PC6) and He-gu (LI4) were stimulated by a transcutaneous acupoint electrical stimulation instrument approximately 30 minutes before anesthesia induction until the patient is discharged from the operating room.

干预措施: triple antiemetic drugs (Drug)

The control group

Sham Comparator

The same protocol was applied for percutaneous acupoint electrical stimulation, initiated before anesthesia induction with the minimum perceptible current (MPC) and terminated after 1 minute. To ensure complete blinding, both groups were covered with opaque sheets over the percutaneous acupoint electrical stimulation device.

干预措施: Sham transcutaneous electrical acupoint stimulation (Device)

The control group

Sham Comparator

The same protocol was applied for percutaneous acupoint electrical stimulation, initiated before anesthesia induction with the minimum perceptible current (MPC) and terminated after 1 minute. To ensure complete blinding, both groups were covered with opaque sheets over the percutaneous acupoint electrical stimulation device.

干预措施: triple antiemetic drugs (Drug)

结局指标

主要结局

Number of Participants Experiencing Nausea,Retching and Vomiting within 24 hours after operation.

时间窗: 2 hours post-operation, 6 hours post-operation, 24 hours post-operation

The number of episodes of nausea, retching and vomiting within 24 hours after operation

次要结局

  • Number of Participants Experiencing Postoperative Nausea in 48 h Postoperatively(2 hours post-operation, 6 hours post-operation, 24 hours post-operation, 48 hours post-operation)
  • Number of Participants Experiencing Postoperative Vomiting in 48 h Postoperatively(2 hours post-operation, 6 hours post-operation, 24 hours post-operation, 48 hours post-operation)
  • Need of Postoperative Metoclopramide(2 hours post-operation, 6 hours post-operation, 24 hours post-operation, 48 hours post-operation)

研究者

发起方
Zhejiang University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Diansan Su

Chair of the Department of Anesthesiology

Zhejiang University

研究点 (1)

Loading locations...

相似试验